This independent HPLC/LC-MS lab test confirms a Cagrilintide/Semaglutide blend (5mg/5mg) from HkRoids at 99.65% total purity. Net peptide content measured at 4.72mg Cagrilintide and 5.72mg Semaglutide. The analysis was conducted by Freedom Diagnostics on July 22, 2025, with both compounds verified via mass spectrometry.
Cagrilintide is an amylin analogue and Semaglutide is a GLP-1 receptor agonist; together they are researched for synergistic effects on appetite suppression, metabolic regulation, and weight management. A total purity of 99.65% indicates high-grade synthesis and minimal contamination across both compounds.
The full certificate of analysis is available for download on this page.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.